Trial Profile
Incidence and risk factors of osteonecrosis of the jaw after treatment with Zoledronic acid or Denosumab in advanced cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Oct 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Zoledronic acid (Primary)
- Indications Breast cancer; Colon cancer; Liver cancer; Lung cancer; Oesophageal cancer; Ovarian cancer; Prostate cancer; Renal cancer
- Focus Therapeutic Use
- 26 Oct 2016 New trial record